But I am clear that mental health claims are speculative, and choosing it specifically for psychiatric benefit is not evidence-based
Gave me a little bit of energy
If we discuss it too casually, we risk normalizing an unapproved drug with limited human evidence and unknown long-term risks
87 The lack of robust human data is the elephant in the room: we simply dont have the clinical trials to know if the amazing results in rats will translate to people, or if long-term use might introduce serious side effects
BPC-157 is a single peptide that primarily targets tendon, ligament, and gut healing through angiogenesis and growth factor modulation
The wrong choice doesnt just affect convenience it can impact how long your peptide vial stays viable, whether bacterial growth becomes a risk, and in rare cases, whether the preservative itself interacts poorly with certain peptide compounds